Over 2,000 Lawsuits Filed Over Blood Thinner, Pradaxa

Today Reuters (2/14, Siebelt, Burger) reported that over 2,000 lawsuits in the US have been filed against the German pharmaceutical firm, Boehringer Ingelheim over its blood thinning medicine, Pradaxa (dabigatran etexilate).  The claims allege that the medicine causes severe and fatal bleeding.  In fact, studies  have established that individuals using the blood thinner have roughly a 33 percent higher risk for fatal health risks associated with the drug as compared to individuals using the blood thinner warfarin.

Pradaxa was designed to replace warfarin to prevent strokes in patients suffering from atrial fibrillation, a form of irregular heartbeat.

For more information on Pradaxa, contact our Pradaxa attorneys at Zoll, Kranz & Borgess toll-free at (888)841-9623 or visit our website www.zkblaw.com.


Leave a Comment